ClinConnect ClinConnect Logo
Search / Trial NCT04160312

Mitopure™ (Proprietary Urolithin A) Bioavailability in Healthy Adults

Launched by AMAZENTIS SA · Nov 8, 2019

Trial Information

Current as of May 14, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Males and females 18 to 80 years of age;
  • 2. Is in general good health, as determined by the clinical research team;
  • 3. Willingness to consume investigational product, complete questionnaires and to complete all clinic visits;
  • 4. Have given voluntary, written, informed consent to participant in the study;
  • Exclusion Criteria:
  • 1. Women who are pregnant, breastfeeding, or planning to become pregnant during the course of the trial;
  • 2. Alcohol or drug abuse within the last 6 months;
  • 3. Volunteers who plan to donate blood during the study or within 30 days of completing the study;
  • 4. Subject has a known allergy to the test material's active or inactive ingredients;
  • 5. Subjects with unstable medical conditions;
  • 6. Clinically significant abnormal laboratory results at screening;
  • 7. Participation in a clinical research trial within 30 days prior to randomization;
  • 8. Allergy or sensitivity to study ingredients; lactose intolerance.
  • 9. Individuals who are cognitively impaired and/or who are unable to give informed consent;
  • 10. Any other condition which in the Investigator's opinion may adversely affect the subject's ability to complete the study or its measures or which may pose significant risk to the subject.
  • 11. Has taken antibiotics within the previous 30 days;

About Amazentis Sa

Amazentis SA is a biotechnology company focused on advancing health through the development of innovative nutritional and therapeutic solutions. With a strong emphasis on scientific research and clinical validation, Amazentis leverages cutting-edge technologies to explore the potential of bioactive compounds in promoting metabolic health and enhancing overall well-being. The company is dedicated to transforming scientific discoveries into effective products that address pressing health challenges while maintaining a commitment to sustainability and evidence-based practices. Through strategic collaborations and rigorous clinical trials, Amazentis aims to contribute significantly to the fields of nutrition and health optimization.

Locations

Chicago, Illinois, United States

Patients applied

0 patients applied

Trial Officials

Ali Keshavarzian, MD

Principal Investigator

Rush University Medical Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials